SAHA and S116836, a novel tyrosine kinase inhibitor, synergistically induce apoptosis in imatinib-resistant chronic myelogenous leukemia cells

	SAHA and S116836, a novel tyrosine kinase inhibitor, synergistically induce apoptosis in imatinib-resistant chronic myelogenous leukemia cells
	Bu, Qiangui ; Cui, Lijing ; Li, Juan ; Du, Xin ; Zou, Waiyi ; Ding, Ke ; Pan, Jingxuan
刊名	CANCER BIOLOGY & THERAPY
	2014
卷号	15 期号:7 页码:951-962
ISSN号	1538-4047
学科主题	Oncology
语种	英语
公开日期	2016-12-16
内容类型	期刊论文
源URL	[http://ir.gibh.ac.cn/handle/344009/321]
专题	广州生物医药与健康研究院_华南干细胞与再生医学研究所_华南干细胞与再生医学研究所_期刊论文
推荐引用方式 GB/T 7714	Bu, Qiangui,Cui, Lijing,Li, Juan,et al. SAHA and S116836, a novel tyrosine kinase inhibitor, synergistically induce apoptosis in imatinib-resistant chronic myelogenous leukemia cells[J]. CANCER BIOLOGY & THERAPY,2014,15(7):951-962.
APA	Bu, Qiangui.,Cui, Lijing.,Li, Juan.,Du, Xin.,Zou, Waiyi.,...&Pan, Jingxuan.(2014).SAHA and S116836, a novel tyrosine kinase inhibitor, synergistically induce apoptosis in imatinib-resistant chronic myelogenous leukemia cells.CANCER BIOLOGY & THERAPY,15(7),951-962.
MLA	Bu, Qiangui,et al."SAHA and S116836, a novel tyrosine kinase inhibitor, synergistically induce apoptosis in imatinib-resistant chronic myelogenous leukemia cells".CANCER BIOLOGY & THERAPY 15.7(2014):951-962.